Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease
- Conditions
- Inflammatory Bowel Diseases
- Registration Number
- NCT05151458
- Lead Sponsor
- Assiut University
- Brief Summary
Ulcerative colitis (UC) and Crohns disease (CD) represent the two major forms of inflammatory bowel disease (IBD), characterized by epithelial cell damage and prominent mucosal infiltration by inflammatory cells including granulocytes, macrophages, lymphocytes, and plasma cells.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
IBD patients diagnosed by endoscopy.
Male and female gender. Disease activity proven clinically and endoscopy . Assiut university hospital patients
Exclusion Criteria
- Patients who refuse to contribute in this study Pregnancy and breast feeding Cancer patients Renal pathology Diabetes Mellitus Cardiovascular patients Pancreatitis COPD patients
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method test the sensitivity and specificity of using NGAL in diagnosis of IBD One year test the sensitivity and specificity of using NGAL in diagnosis of IBD
- Secondary Outcome Measures
Name Time Method